Dr. Van Buren is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1919 Old Spanish Trail
6th Floor
Houston, TX 77054Phone+1 832-957-6500Fax+1 713-610-4597
Summary
- George Van Buren, II, M.D. is a professor of surgery in the Division of Surgical Oncology of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine. Dr. Van Buren is a board-certified surgeon specializing surgical oncology and pancreatic disorders.
Dr. Van Buren earned his undergraduate degree at the University of Texas at Austin and his medical degree at the University of Texas Medical School at Houston. He completed his general surgery residency at the University of Texas Medical School at Houston. During that time period, he spent two years at MD Anderson Cancer Center as an NIH T32 research fellow studying pancreatic cancer, colorectal cancer, and neuroendocrine tumors. He completed his surgical oncology fellowship at the University of Pittsburgh Medical Center in the Translational Pancreas Research Track.
During Dr. Van Buren’s research and clinical fellowships, he was able to expand upon his interest in gastrointestinal surgical oncology. Specifically, his training had a heavy emphasis on upper gastrointestinal and hepatobiliary malignancies with exposure to wide breadth of cases, including specialized procedures such as robotic pancreatic surgery and minimally invasive lower gastrointestinal surgery.
Dr. Van Buren is active in both patient care and research. He has been involved in both basic science and clinical research and believes heavily in the surgeon’s role as a leader of the translational research team. His goals are to provide high quality clinical care while offering his patients access to innovative clinical and therapeutic trials.
Education & Training
- Rice UniversityNo Degree, Certificate in Healthcare Management, 2014 - 2015
- UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2010 - 2012
- University of Texas Health Science Center at HoustonResidency, Surgery, 2003 - 2010
- University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2005 - 2007
- McGovern Medical School at UTHealthClass of 2003
- The University of Texas SystemB.A., Biology, 1996 - 1999
- Johns Hopkins UniversityBachelor's, Biology, 1995 - 1996
Certifications & Licensure
- TX State Medical License 2007 - 2025
- PA State Medical License 2010 - 2012
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Top Doctors Houstonia Magazine, 2015
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Pancreas Club Resident/ Fellow Award 2012
- Join now to see all
Publications & Presentations
PubMed
- Interobserver Variability and Challenges in Intraoperative Frozen Section Evaluation of Pancreatic Margins in Pancreatectomy Specimens.Sadhna Dhingra, Melissa W Taggart, Wai Chin Foo, Asif Rashid, Maria Luisa Machado Heredia
Annals of Clinical and Laboratory Science. 2023-11-01 - 13 citationsCD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer.Erika Y Faraoni, Kanchan Singh, Vidhi Chandra, Olivereen Le Roux, Yulin Dai
Cancer Research. 2023-04-04 - 1 citationsPretreatment Health-Related Quality-of-Life Status and Survival in Pancreatobiliary Surgical Patients.Naveen Manisundaram, Jorge I Portuondo, Derek Erstad, Eric Silberfein, Cary Hsu
Journal of the American College of Surgeons. 2023-04-01
Journal Articles
- Pancreaticoduodenectomy Without Drains: Interpretation of the EvidenceVan Buren G 2nd, Fisher WE, Ann Surg, 1/1/2015
- Treatment of bacteriobilia decreases wound infection rates after pancreaticoduodenectomyMohammed S, Evans C, Hodges SE, Silberfein E, Artinyan A, Mo Q, Issazadeh M, McElhany AL, Fisher WE, HPB (Oxford), 1/29/2013
- An assessment of the necessity of transfusion during pancreatoduodenectomyRoss A, Mohammed S, Silberfein EJ, Artinyan A, Hodges SE, Fisher WE, Surgery, 1/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- The Impact of Level One Data on Pancreatic Surgical PracticeMederos MA, McElhany A, Mohammed S, Fisher WE, Debakey Department of Surgery Research Day, Houston, TX, 1/3/2015
- The Impact Of Inappropriate Blood Transfusion During PancreaticoduodenectomyMohammed S, Ross A, Silberfein EJ, Artinyan A, Hodges SE, Fisher WE, ASC 2013, New Orleans, 1/1/2013
- Phase II trial of fixed-dose rate gemcitabine, bevacizumab, and concurrent 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarc...Ramanathan R, Krasinskas A, Smith R, Abood G, Shaui Y, Potter D, Bahary N, Lembersky B, Zureikat AH, Bartlett DL, Zeh HJ, Moser AJ, ASCO 2012 Gastrointestinal Cancers Symposium, 1/1/2012
- Join now to see all
Lectures
- Faculty Education and Development: Maintenance of CertificationBaylor College of Medicine - 1/9/2015
- A Randomized Prospective Multicenter Trial of Pancreaticoduodenectomy With and Without Routine Intraperitoneal Drainage1/1/2014
- Colon Adenocarcinoma Lymph Node Analysis1/1/2014
- Join now to see all
Professional Memberships
- Member
- Member
- Fellow
- Member
Other Languages
- Spanish
External Links
- bcm linkhttps://www.bcm.edu/people/view/b17dfc07-ffed-11e2-be68-080027880ca6
- twittergeorgevanburenhttps://twitter.com/GeorgeVanBuren
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: